Showing results for 
Search instead for 
Did you mean: 

WEBINAR: Theranostics & You | Riding the pipeline of personalisation in new nuclear medicines

Community Manager
Community Manager
0 0 83

If you’ve been impacted by prostate cancer, the term ‘theranostics’ is probably at the top of your news list. The rapidly emerging treatment modality combines therapy and diagnostics to improve our understanding of each man’s cancer, and how it can be effectively treated, heralding a complete transformation of care.

Impressively, Australia has rapidly established itself as a global pioneer in the field, with clinical trials such as the ProPSMA study and TheraP delivering groundbreaking findings that have helped to establish new standards of care locally and globally.

In this webinar, we bring together experts and survivors to talk about theranostics and you – knowing when to go nuclear, and whether it will work.

Thank you to PCFA’s Major Partner TENA for supporting this webinar.


Matthew Britland

President, Medical Affairs Professionals of Australasia

Matt is the President of the Australian Pharmaceutical Medical and Scientific Professionals Association (APPA), the representative association for Medical Affairs Professionals of Australasia. He is also the Managing Director of MedWise Consulting, a specialist practice focused on medical affairs, medical and scientific communications, and patient engagement. Matt is an experienced medical affairs leader and Medical Director with a demonstrated history of working in the pharmaceuticals industry and clinical roles for over 20 years. Skilled in Pharmaceutical Medicine, Oncology and Haematology, Matt is a strong professional with a MMedSc focused in Pharmaceutical Medicine from UNSW Australia. He is currently undertaking a PhD on the role of Medical Affairs in the Quality use of Medicine (QUM) and its impact on patient outcomes.


Dr David Cade

Chief Executive Officer, Telix Asia Pacific

Dr Cade has over 20 years of experience as an industry physician spanning the fields of novel biotechnology, pharmaceuticals and medical devices. Prior to joining Telix, David held senior executive roles at Cochlear Limited (ASX: COH), where he served as Chief Medical Officer, and at Sirtex Medical Limited (ASX: SRX), where he served as Chief Medical Officer and in other senior roles across the US, Europe and Australia, gaining deep experience in the Oncology, Interventional Radiology and Nuclear Medicine therapeutic areas. Earlier in his career David trained in surgery at Monash Medical Centre in Melbourne and worked at management consultancy, Booz & Company across the Asia Pacific. David holds an MBBS from Monash Medical School, an MBA from Melbourne Business School and ESADE Business and Law School Barcelona, and is a Graduate of the Australian Institute of Company Directors.

Associate Professor Shahneen Sandhu

Consultant Medical Oncologist & Researcher, Peter MacCallum Cancer Centre

Associate Professor Shahneen Sandhu is a consultant medical oncologist and a leading clinician researcher with a full time appointment in the melanoma/skin and
uro-oncology units at the Peter MacCallum Centre, Melbourne. Her research is currently focused on the design, conduct and analysis of early clinical trials with novel drugs that aim to co-develop predictive biomarkers in conjunction with therapeutics in order to personalise treatment and improve patient outcome. Her training and research experience have provided her with a diverse range of skills in the conduct of clinical and translational research studies. She has led trials from phase I concept development all the way to registration of the compound and companion diagnostic for optimal patient selection. She currently leads several multicentre investigator-initiated trials and multiple collaborative biomarker translational projects evaluating the immune landscape in melanoma, merkel cell carcinoma and prostate cancer. Associate Professor Sandhu has >192 peer reviewed publications including, 39 first or last author publications in premier journals. This work has largely focused on the development of Poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian, breast and prostate cancer, evaluating immunotherapy combination therapies and immune related toxicities and developing prognostic and predictive circulating biomarkers (circulating tumour cells, circulating tumour DNA, mRNA) in prostate cancer and melanoma.

Will McDonald

Presenter/Reporter/Producer, Nine News

Will McDonald is a Nine News presenter, reporter and producer. He presents the 6pm weekend bulletin for Nine News in Adelaide and the afternoon weekday news. Born in Adelaide, Will’s media career began in 2000 in Port Lincoln for Southern Cross News. Writing, filming and editing his own stories, he then moved to Port Pirie to host the local news bulletin. In over two decades of journalism, Will has covered major Australian news stories, from ground-breaking medical research to catastrophic bushfires. Outside of work, he’s a motorcycle enthusiast who loves adventure, including hiking, mountain climbing and skydiving as often as he can. Will was diagnosed with advanced prostate cancer in July 2020 at the age of 42 and is determined to beat it. He and his partner Samantha welcomed their first son in January 2023, a baby boy named Alfie, and he recently completed his first Ironman event, raising over $25,000 for Prostate Cancer Foundation of Australia.

House Rules

To help keep this community a welcoming, supportive and caring place we have put together a small list of dos and don'ts for you to think about when posting on our forum, research blog or video gallery. For further information please see our  terms and conditions.

Adhere to PCFA’s five core values of Integrity, Optimism, Compassion, Respect and Commitment.

Our online forum is for you to share experiences with others and does not contain specific medical, counselling or legal advice.  If you require professional advice specific to your individual circumstances we encourage you to see a medical professional, legal professional or counsellor.

No commercial or promotional activity. While members may share information about resources they have found helpful, the PCFA Online Community forum should not be used for the promotion of goods and services. This includes commercial entities passing themselves off as individuals and people who frequently post links to external health professionals or other services.

Be kind to each other - many people using the community are going through a difficult time. A few kind words can go a long way. Please welcome new posters – it can be very nerve-wracking to post on the forum for the first time.

If you or someone you know is suffering from mental health issues, such as depression or anxiety, we encourage you to seek assistance and contact Beyond Blue Tel:1300 224 636 or Lifeline Tel:13 11 14

Speak your mind freely, but please be sensitive to the feelings and experiences of others - you might not always agree, but you can agree to disagree in a peaceful manner.

Don't use offensive language -if a user is found to be using offensive language during their conversations the moderators reserve the right to edit the thread, without warning.

Don't use all capital letters in your posts - it's considered ‘shouting' online and it makes posts difficult to read.

Give each other the benefit of the doubt - please remember that it is all too easy for the tone and meaning of posts to be misinterpreted. Think carefully before replying to a discussion. it It is important to remember that things written rather than said can feel much stronger, so please bear this in mind when reading other people's messages.

Please respect the moderators - their job is to keep the forum safe and constructive so that everybody gets to have his or her fair say.

Stay on topic - try to focus on the original topic. In particular, don't change subject in the middle of an existing thread - just start a new thread.

Read what's already on the forum before posting - you may be repeating what others have already said or asked.

We want PCFA's Online Community to be a secure and helpful environment for all of the community. So please remember that by using PCFA's Online Community you are agreeing to follow our terms and conditions.